Mycophenolate Mofetil (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Mycophenolate Mofetil drug offered from Cadila Healthcare Limited. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Mycophenolate Mofetil |
SUBSTANCE NAME: | MYCOPHENOLATE MOFETIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-09-22 |
END MARKETING DATE: | 0000-00-00 |
Mycophenolate Mofetil HUMAN PRESCRIPTION DRUG Details:
Item Description | Mycophenolate Mofetil from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/20mL) |
START MARKETING DATE: | 2017-09-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70771-1084_f53d29cf-87b2-49b2-8050-b4a4223a8273 |
PRODUCT NDC: | 70771-1084 |
APPLICATION NUMBER: | ANDA204473 |
Other MYCOPHENOLATE MOFETIL Pharmaceutical Manufacturers / Labelers: